Browse Categories
- Notice
UroToday
| C2R 2009 - Case Discussions - Session Highlights |
 |
 |
Tue, 29 September 2009
|
Christopher P. Evans, MD
Last Updated ( Tue, 29 September 2009 )
Login to read more...| C2R 2009 - Prostate cancer screening recommendations of the US Preventive Services Task Force - Session Highlights |
|
|
Tue, 29 September 2009
|
Christopher P. Evans, MD
Last Updated ( Tue, 29 September 2009 )
Login to read more...| C2R 2009 - Mitochondrial DNA deletions: A functional biomarker for prostate cancer - Session Highlights |
|
|
Tue, 29 September 2009
|
Christopher P. Evans, MD
Last Updated ( Tue, 29 September 2009 )
Login to read more...| C2R 2009 - General Session: Tailoring urologic treatments to the spectrum of disease - Session Highlights |
|
|
Tue, 29 September 2009
|
Christopher P. Evans, MD
Last Updated ( Tue, 29 September 2009 )
Login to read more...| C2R 2009 - Town Hall Discussion: The prostate screening controversy - Session Highlights |
|
|
Tue, 29 September 2009
|
Christopher P. Evans, MD
Last Updated ( Tue, 29 September 2009 )
Login to read more...| C2R 2009 - Town Hall Discussion: Androgen replacement versus 5-ARIs - Who should get what? - Session Highlights |
|
|
Tue, 29 September 2009
|
Christopher P. Evans, MD
Last Updated ( Tue, 29 September 2009 )
Login to read more...